1-6 of 6
Christine L. Kempton
Close
Sort by
Journal Articles

Race and ethnicity reporting and representation in hemophilia clinical trials

Clinical Trials & Observations
Stacey A. Fedewa, Leonard A. Valentino, Andee Koo, Lorraine Cafuir, Duc Q. Tran, Ana Antun, Christine L. Kempton
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2351–2360.
https://doi.org/10.1182/bloodadvances.2024012862
Published: 2024
Journal Articles

Defining the impact of immune tolerance induction on clinically relevant outcomes in a US cohort of severe hemophilia A

Christine L. Kempton, Stacey A. Fedewa
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1190–1199.
https://doi.org/10.1182/bloodadvances.2023011974
Published: 2024
Includes: Supplemental data
Journal Articles

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies

Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, Tiffany Chang, Sammy Chebon, Michelle Y. Doral, Stacy E. Croteau, Thierry Lambert, Christine L. Kempton, Steven W. Pipe, Richard H. Ko, Benjamin Trzaskoma, Christophe Dhalluin, Nives Selak Bienz, Markus Niggli, Michaela Lehle, Ido Paz-Priel, Guy Young, Víctor Jiménez-Yuste
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6140–6150.
https://doi.org/10.1182/bloodadvances.2022007458
Published: 2022
Includes: Supplemental data
Journal Articles

Inhibitors and mortality in persons with nonsevere hemophilia A in the United States

Clinical Trials & Observations
Ming Y. Lim, Dunlei Cheng, Michael Recht, Christine L. Kempton, Nigel S. Key
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4739–4747.
https://doi.org/10.1182/bloodadvances.2020002626
Published: 2020
Includes: Supplemental data
Journal Articles

Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice

M. Neale Weitzmann, Susanne Roser-Page, Tatyana Vikulina, Daiana Weiss, Li Hao, W. Hunter Baldwin, Kanglun Yu, Natalia del Mazo Arbona, Meghan E. McGee-Lawrence, Shannon L. Meeks, Christine L. Kempton
Journal: Blood Advances
Blood Adv (2019) 3 (3): 288–300.
https://doi.org/10.1182/bloodadvances.2018027557
Published: 2019
Includes: Supplemental data
Journal Articles

HLA-DRB1–factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study

Christine L. Kempton, Amanda B. Payne
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1750–1755.
https://doi.org/10.1182/bloodadvances.2018019323
Published: 2018